Aquestive Therapeutics, Inc. Business Finance Contracts & Agreements

31 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Aquestive Therapeutics, Inc. Underwriting Agreement with Leerink Partners LLC and Piper Sandler & Co. (March 2024)
Underwriting Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2024
Securities Purchase Agreement between Aquestive Therapeutics, Inc. and Purchasers (June 6, 2022)
Purchase Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2022
Placement Agent Agreement between Aquestive Therapeutics, Inc. and A.G.P./Alliance Global Partners (June 6, 2022)
Equity Distribution Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
2022
Amendment No. 2 to Purchase Agreement between Aquestive Therapeutics, Inc. and Purchasers
Purchase Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2022
Fifth Supplemental Indenture to 12.5% Senior Secured Notes Due 2025 between Aquestive Therapeutics, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2022
Amendment No. 1 to Equity Distribution Agreement between Aquestive Therapeutics, Inc. and Piper Sandler & Co.
Equity Distribution Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2021
Purchase and Sale Agreement between Aquestive Therapeutics, Inc. and MAM Pangolin Royalty, LLC (November 3, 2020)
Purchase Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2021
Purchase Agreement for 12.5% Senior Secured Notes Due 2025 between Aquestive Therapeutics, Inc. and Purchaser
Purchase Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2021
Second Supplemental Indenture to 12.5% Senior Secured Notes Due 2025 between Aquestive Therapeutics, Inc. and U.S. Bank National Association (November 19, 2020)
Indenture Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2021
First Supplemental Indenture to 12.5% Senior Secured Notes Due 2025 between Aquestive Therapeutics, Inc. and U.S. Bank National Association (November 3, 2020)
Indenture Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2021
Aquestive Therapeutics, Inc. Employee Stock Purchase Plan (as Amended January 2020)
Equity Distribution Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
DE
2020
Description of Capital Stock of Aquestive Therapeutics, Inc.
Stock Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
2020
Underwriting Agreement between Aquestive Therapeutics, Inc. and BMO Capital Markets Corp. (December 12, 2019)
Underwriting Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2019
Indenture for 12.5% Senior Secured Notes due 2025 between Aquestive Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2019
Collateral Agreement among Aquestive Therapeutics, Inc., U.S. Bank National Association (Trustee and Collateral Agent), and Other Grantors (July 15, 2019)
Security Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2019
Purchase Agreement for $70,000,000 12.5% Senior Secured Notes Due 2025 and Warrants between Aquestive Therapeutics, Inc. and Purchaser
Purchase Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2019
Aquestive Therapeutics, Inc. Employee Stock Purchase Plan (2019)
Stock Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
DE
2019
Underwriting Agreement between Aquestive Therapeutics, Inc. and BMO Capital Markets Corp. and RBC Capital Markets, LLC
Underwriting Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2018
Aquestive Therapeutics, Inc. Stock Option Agreement with Optionee (2018)
Stock Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
DE
2018
Payment and Royalty Agreement between MonoSol Rx, LLC and Indivior Inc. and Indivior UK Limited (September 24, 2017)
Financing Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
DE
2018
Omnibus Amendment No. 1 to Credit Agreement and Related Loan Documents among MonoSol Rx, LLC (to be renamed Aquestive Therapeutics, Inc.), Lenders, and Perceptive Credit Holdings,...
Modification Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2018
Monosol Rx, Inc. Restricted Stock Agreement with Executive under 2007 Stock Incentive Plan
Stock Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
DE
2007
Common Stock Purchase Warrant Agreement between Aquestive Therapeutics, Inc. and Holder (June 8, 2022)
Warrant Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
2022
Pre-Funded Common Stock Purchase Warrant Agreement between Aquestive Therapeutics, Inc. and Holder (June 8, 2022)
Warrant Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
2022
Paycheck Protection Program Promissory Note between Frost Bank and Aquestive Therapeutics Inc.
Note Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
TX
2020
Aquestive Therapeutics, Inc. Common Stock Purchase Warrant Agreement with Holder
Warrant Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2019
Amendment No. 2 to Credit Agreement and Guaranty among Aquestive Therapeutics, Inc., Perceptive Credit Holdings, LP, and Lenders
Credit Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2018
Credit Agreement and Guaranty between MonoSol Rx, LLC and Perceptive Credit Holdings, LP, dated August 16, 2016
Credit Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2018
Registration Rights Agreement among Aquestive Therapeutics, Inc., Aquestive Partners, LLC, and Security Holders
Registration Rights Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NJ
2018
Warrant Agreement between Aquestive Partners, LLC and Holders Dated January 1, 2018
Warrant Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2018
Monosol Rx, Inc. Stock Option Agreement under 2007 Stock Incentive Plan
Warrant Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
2007